Trial Profile
Evaluation of Phenotypic and Genetic Properties in Male Subjects With Hypohidrotic Ectodermal Dysplasia and Their Family Members
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs DMX 101 (Primary)
- Indications Ectodermal dysplasia
- Focus Therapeutic Use
- Sponsors Edimer Pharmaceuticals
- 07 Nov 2014 New trial record